๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Bevacizumab and everolimus in the treatment of patients with metastatic melanoma : A phase 2 trial of the Sarah Cannon Oncology Research Consortium

โœ Scribed by John D. Hainsworth; Jeffrey R. Infante; David R. Spigel; James D. Peyton; Dana S. Thompson; Cassie M. Lane; Bobby L. Clark; Mark S. Rubin; David F. Trent; Howard A. Burris III


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
197 KB
Volume
116
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


A phase III randomized trial of dacarbaz
โœ Sanjiv S. Agarwala; William Ferri; William Gooding; John M. Kirkwood ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 90 KB ๐Ÿ‘ 3 views

## BACKGROUND. Metastatic melanoma is a disease associated with a poor prognosis, and dacarbazine is still the reference agent. The authors conducted a randomized trial to test the benefit of adding tamoxifen to dacarbazine and carboplatin chemotherapy for previously untreated patients with metast